OBJECTIVE: To describe the use of stem cells (SCs) for regeneration of retinal degenerations. Regenerative medicine intends to provide therapies for severe injuries or chronic diseases where endogenous repair does not sufficiently restore the tissue. Pluripotent SCs, with their capacity to give rise to specialized cells, are the most promising candidates for clinical application. Despite encouraging results, a combination with up-to-date tissue engineering might be critical for ultimate success. DESIGN: The focus is on the use of SCs for regeneration of retinal degenerations. Cell populations include embryonic, neural, and bone marrow-derived SCs, and engineered grafts will also be described. RESULTS: Experimental approaches have successfully replaced damaged photoreceptors and retinal pigment epithelium using endogenous and exogenous SCs. CONCLUSIONS: Stem cells have the potential to significantly impact retinal regeneration. A combination with bioengineering may bear even greater promise. However, ethical and scientific issues have yet to be solved.
OBJECTIVE: To describe the use of stem cells (SCs) for regeneration of retinal degenerations. Regenerative medicine intends to provide therapies for severe injuries or chronic diseases where endogenous repair does not sufficiently restore the tissue. Pluripotent SCs, with their capacity to give rise to specialized cells, are the most promising candidates for clinical application. Despite encouraging results, a combination with up-to-date tissue engineering might be critical for ultimate success. DESIGN: The focus is on the use of SCs for regeneration of retinal degenerations. Cell populations include embryonic, neural, and bone marrow-derived SCs, and engineered grafts will also be described. RESULTS: Experimental approaches have successfully replaced damaged photoreceptors and retinal pigment epithelium using endogenous and exogenous SCs. CONCLUSIONS: Stem cells have the potential to significantly impact retinal regeneration. A combination with bioengineering may bear even greater promise. However, ethical and scientific issues have yet to be solved.
Authors: Botir T Sagdullaev; Robert B Aramant; Magdalene J Seiler; Gustaw Woch; Maureen A McCall Journal: Invest Ophthalmol Vis Sci Date: 2003-04 Impact factor: 4.799
Authors: Joshua D Dowell; Michael Rubart; Kishore B S Pasumarthi; Mark H Soonpaa; Loren J Field Journal: Cardiovasc Res Date: 2003-05-01 Impact factor: 10.787
Authors: Anna Pituch-Noworolska; Marcin Majka; Anna Janowska-Wieczorek; Monika Baj-Krzyworzeka; Barbara Urbanowicz; Edward Malec; Mariusz Z Ratajczak Journal: Folia Histochem Cytobiol Date: 2003 Impact factor: 1.698
Authors: Noel M Caplice; T Jared Bunch; Paul G Stalboerger; Shaohua Wang; David Simper; Dylan V Miller; Stephen J Russell; Mark R Litzow; William D Edwards Journal: Proc Natl Acad Sci U S A Date: 2003-03-28 Impact factor: 11.205
Authors: Eva Mezey; Sharon Key; Georgia Vogelsang; Ildiko Szalayova; G David Lange; Barbara Crain Journal: Proc Natl Acad Sci U S A Date: 2003-01-21 Impact factor: 11.205
Authors: Ryan Reca; Dimitrios Mastellos; Marcin Majka; Leah Marquez; Janina Ratajczak; Silvia Franchini; Aleksandra Glodek; Marek Honczarenko; Lynn A Spruce; Anna Janowska-Wieczorek; John D Lambris; Mariusz Z Ratajczak Journal: Blood Date: 2003-01-02 Impact factor: 22.113
Authors: Stephen J Phillips; Srinivas R Sadda; Mark O M Tso; Mark S Humayan; Eugene de Juan; Susanne Binder Journal: Curr Eye Res Date: 2003-02 Impact factor: 2.424
Authors: Mandeep S Singh; Susanna S Park; Thomas A Albini; M Valeria Canto-Soler; Henry Klassen; Robert E MacLaren; Masayo Takahashi; Aaron Nagiel; Steven D Schwartz; Kapil Bharti Journal: Prog Retin Eye Res Date: 2019-09-05 Impact factor: 21.198